ATE497973T1 - Rekombinante produktion heparinbindender proteine - Google Patents

Rekombinante produktion heparinbindender proteine

Info

Publication number
ATE497973T1
ATE497973T1 AT06850998T AT06850998T ATE497973T1 AT E497973 T1 ATE497973 T1 AT E497973T1 AT 06850998 T AT06850998 T AT 06850998T AT 06850998 T AT06850998 T AT 06850998T AT E497973 T1 ATE497973 T1 AT E497973T1
Authority
AT
Austria
Prior art keywords
heparin
binding proteins
recombinant production
recombinant
production
Prior art date
Application number
AT06850998T
Other languages
English (en)
Inventor
Michelle D Butler
Jeffrey L Cleland
David W Kahn
Shelly Pizarro
Charles H Schmelzer
Marjorie E Winkler
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE497973T1 publication Critical patent/ATE497973T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT06850998T 2005-12-22 2006-12-19 Rekombinante produktion heparinbindender proteine ATE497973T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75361505P 2005-12-22 2005-12-22
US80743206P 2006-07-14 2006-07-14
PCT/US2006/062320 WO2007130154A2 (en) 2005-12-22 2006-12-19 Recombinant production of heparin binding proteins

Publications (1)

Publication Number Publication Date
ATE497973T1 true ATE497973T1 (de) 2011-02-15

Family

ID=38668202

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06850998T ATE497973T1 (de) 2005-12-22 2006-12-19 Rekombinante produktion heparinbindender proteine

Country Status (16)

Country Link
US (3) US20080032343A1 (de)
EP (2) EP2336164A1 (de)
JP (2) JP5036727B2 (de)
KR (1) KR101067525B1 (de)
AR (1) AR058625A1 (de)
AT (1) ATE497973T1 (de)
AU (1) AU2006343279B2 (de)
BR (1) BRPI0621124A2 (de)
CA (1) CA2633554C (de)
DE (1) DE602007012412D1 (de)
IL (1) IL191968A (de)
MY (1) MY143274A (de)
NZ (1) NZ568809A (de)
RU (1) RU2385877C1 (de)
TW (1) TWI369362B (de)
WO (1) WO2007130154A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ568809A (en) 2005-12-22 2011-08-26 Genentech Inc Recovering and purification of VEGF proteins from prokaryotic cells using polyanionic agents
AU2007272412B2 (en) 2006-07-14 2013-11-07 Genentech, Inc. Refolding of recombinant proteins
CA2742817A1 (en) 2008-11-20 2010-05-27 Biogen Idec Ma Inc. Arginine inactivation of viruses
CN102482321B (zh) 2009-06-22 2015-06-17 安姆根有限公司 使用化学控制的氧化还原态重折叠蛋白质
WO2010151688A2 (en) 2009-06-25 2010-12-29 Amgen Inc. Capture purification processes for proteins expressed in a non-mammalian system
ES2953895T3 (es) 2010-02-25 2023-11-16 John Clement Preston Andamio
KR102283127B1 (ko) * 2018-06-19 2021-07-29 주식회사 엠디헬스케어 류코노스톡속 균주를 포함하는 간 기능 개선용 조성물
EP3931303A1 (de) * 2019-12-06 2022-01-05 Regeneron Pharmaceuticals, Inc. Anti-vegf-pflanzenproteinzusammensetzungen und verfahren zur herstellung davon

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4169950A (en) * 1977-12-08 1979-10-02 Research Organics Amino-hydroxy-alkyl sulfonic acid zwitterions
US4263428A (en) 1978-03-24 1981-04-21 The Regents Of The University Of California Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
US4565785A (en) * 1978-06-08 1986-01-21 The President And Fellows Of Harvard College Recombinant DNA molecule
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
EP0052322B1 (de) 1980-11-10 1985-03-27 Gersonde, Klaus, Prof. Dr. Verfahren zur Herstellung von Lipid-Vesikeln durch Ultraschallbehandlung, Anwendung des Verfahrens und Vorrichtung zur Durchführung des Verfahrens
US4485045A (en) 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
JPS58118008A (ja) 1982-01-06 1983-07-13 Nec Corp デ−タ処理装置
DE3374837D1 (en) 1982-02-17 1988-01-21 Ciba Geigy Ag Lipids in the aqueous phase
DE3218121A1 (de) 1982-05-14 1983-11-17 Leskovar, Peter, Dr.-Ing., 8000 München Arzneimittel zur tumorbehandlung
EP0102324A3 (de) 1982-07-29 1984-11-07 Ciba-Geigy Ag Lipide und Tenside in wässriger Phase
US4673641A (en) 1982-12-16 1987-06-16 Molecular Genetics Research And Development Limited Partnership Co-aggregate purification of proteins
US4512922A (en) * 1982-12-22 1985-04-23 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4511502A (en) * 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4511503A (en) * 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4544545A (en) 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
US4710473A (en) * 1983-08-10 1987-12-01 Amgen, Inc. DNA plasmids
ATE159858T1 (de) 1983-09-26 1997-11-15 Ehrenfeld Udo Mittel und erzeugnis für die diagnose und therapie von tumoren sowie zur behandlung von schwächen der zelligen und humoralen immunabwehr
DE3474511D1 (en) 1983-11-01 1988-11-17 Terumo Corp Pharmaceutical composition containing urokinase
US4795706A (en) 1985-01-31 1989-01-03 Eli Lilly And Company Novel expression control sequences
ES8800957A1 (es) 1985-02-22 1987-12-01 Monsanto Co Un metodo para la solubilizacion y renaturalizacion de proteina somatotropina
US5453363A (en) * 1985-10-23 1995-09-26 Boehringer Mannheim Gmbh Process for the activation of t-PA or Ing after genetic expression in prokaryotes
AU614137B2 (en) 1988-06-06 1991-08-22 Takeda Chemical Industries Ltd. Stabilized fgf composition and production thereof
DE3835350A1 (de) * 1988-10-17 1990-04-19 Boehringer Mannheim Gmbh Aktivierung von gentechnologisch hergestellten, in prokaryonten exprimierten antikoerpern
US5332671A (en) * 1989-05-12 1994-07-26 Genetech, Inc. Production of vascular endothelial cell growth factor and DNA encoding same
US5194596A (en) 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
US5288931A (en) 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
US5304472A (en) 1992-11-20 1994-04-19 Genentech, Inc. Method of controlling polypeptide production in bacterial cells
US5342763A (en) 1992-11-23 1994-08-30 Genentech, Inc. Method for producing polypeptide via bacterial fermentation
JPH08503950A (ja) 1992-12-02 1996-04-30 アルカーメス・コントロールド・セラピユーテイクス・インコーポレーテツド 徐放性成長ホルモン含有マイクロスフェア
US5331095A (en) 1993-04-12 1994-07-19 Scios Nova Inc. Process for purification of basic fibroblast growth factor
JP4098372B2 (ja) * 1993-07-28 2008-06-11 三菱化学株式会社 ヘパリン結合性増殖因子の生産方法
US5663304A (en) 1993-08-20 1997-09-02 Genentech, Inc. Refolding of misfolded insulin-like growth factor-I
US5464815A (en) 1993-09-08 1995-11-07 Genentech, Inc. Inhibition of heparin-binding
ATE309360T1 (de) * 1994-03-08 2005-11-15 Human Genome Sciences Inc Vaskularer endothelialer wachstumsfaktor 2
PL316935A1 (en) * 1994-04-21 1997-02-17 Novo Nordisk As Heparin bonding protein for treating septicaemia and method of obtaining such protein
ES2151079T3 (es) 1994-09-09 2000-12-16 Takeda Chemical Industries Ltd Preparacion de liberacion sostenida que contiene una sal metalica de un peptido.
FR2729972B1 (fr) * 1995-01-31 1997-04-18 Sanofi Sa Procede d'extraction de proteines periplasmiques de microorganismes procaryotes en presence d'arginine
WO1996040072A2 (en) 1995-06-07 1996-12-19 Alkermes Controlled Therapeutics, Inc. Composition for sustained release of human growth hormone
ZA965368B (en) 1995-07-14 1997-01-14 Novo Nordisk As A pharmaceutical formulation
US6750044B1 (en) 1996-10-17 2004-06-15 Genentech, Inc. Variants of vascular endothelial cell growth factor having antagonistic properties, nucleic acids encoding the same and host cells comprising those nucleic acids
US6632425B1 (en) * 1997-03-20 2003-10-14 Human Genome Sciences, Inc. Chemokine compositions
DE19735711C2 (de) 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken
US6653098B1 (en) 1998-02-23 2003-11-25 G. D. Searle & Co. Method of producing mouse and human endostatin
DK1066328T3 (da) 1998-03-31 2009-02-09 Tonghua Gantech Biotechnology Kimært protein, der indeholder en intramolekylær chaperon-lignende sekvens, og dets anvendelse til insulinproduktion
ES2228052T3 (es) 1998-06-01 2005-04-01 Genentech, Inc. Separacion demonomeros de anticuerpos de sus multimeros utilizando cromatografia de intercambio de iones.
PT1124941E (pt) 1998-10-28 2004-02-27 Genentech Inc Processo para recuperar polipeptidos heterologos a partir de celulas bacterianas
US6783953B1 (en) * 1998-12-22 2004-08-31 Janssen Pharmaceutica N.V. Vascular endothelial growth factor-X
WO2000071716A2 (en) * 1999-05-20 2000-11-30 Scios Inc. Vascular endothelial growth factor dimers
ES2287044T3 (es) 2000-01-25 2007-12-16 Oklahoma Medical Research Foundation Procedimiento universal para el replegamiento de proteinas recombinantes.
AUPQ568100A0 (en) * 2000-02-16 2000-03-09 Amrad Operations Pty. Limited A method for producing recombinant molecules
CA2404567A1 (en) * 2000-03-30 2001-10-11 Takeda Chemical Industries, Ltd. Process for producing recombinant protein
CN1318443C (zh) 2000-05-16 2007-05-30 博尔德生物技术公司 含游离半胱氨酸残基的蛋白重折叠的方法
US7611711B2 (en) * 2001-01-17 2009-11-03 Vegenics Limited VEGFR-3 inhibitor materials and methods
RU2316563C2 (ru) 2001-02-23 2008-02-10 Иммьюнекс Корпорейшн Способ промотирования активной конформации гликозилированного рекомбинантного белка, способ получения активного гликозилированного белка и способ получения композиции указанного белка для введения потребителю и/или пациенту или потребления потребителем и/или пациентом
CA2483142A1 (en) 2002-05-06 2003-11-20 Genentech, Inc. Use of vegf for treating bone defects
WO2003103581A2 (en) 2002-06-05 2003-12-18 Genentech, Inc. Compositions and methods for liver growth and liver protection
AU2004230670B2 (en) 2003-01-09 2010-11-25 Genentech, Inc. Purification of polypeptides
EP1449848A1 (de) 2003-02-20 2004-08-25 GBF German Research Centre for Biotechnology Verfahren zur Herstellung von Proteinen aus der Cystine-Knoten-Familie
AU2004303783A1 (en) 2003-12-10 2005-07-07 Eli Lilly And Company Muteins of fibroblast growth factor 21
DE102004015965A1 (de) 2004-04-01 2005-10-20 Aventis Pharma Gmbh Verfahren zur Gewinnung von Insulinen durch verbesserte Luftbegasung der Faltung
US8362206B2 (en) 2004-06-28 2013-01-29 Yeda Research And Development Co. Ltd. Chimeric proteins and uses thereof
NZ555353A (en) 2004-11-22 2009-12-24 Anaphore Inc TNF antagonists
DE602006003108D1 (de) * 2005-03-03 2008-11-27 Ajinomoto Kk Methode zur Verbesserung der Ausbeute bei der Proteinreinigung mittels Gelfiltrationschromatographie und Arginin
NZ568809A (en) 2005-12-22 2011-08-26 Genentech Inc Recovering and purification of VEGF proteins from prokaryotic cells using polyanionic agents

Also Published As

Publication number Publication date
AR058625A1 (es) 2008-02-13
RU2008130072A (ru) 2010-01-27
JP2009521232A (ja) 2009-06-04
US20130217867A1 (en) 2013-08-22
IL191968A (en) 2013-06-27
KR101067525B1 (ko) 2011-09-27
AU2006343279B2 (en) 2012-03-29
MY143274A (en) 2011-04-15
US20080032343A1 (en) 2008-02-07
NZ568809A (en) 2011-08-26
CA2633554A1 (en) 2007-11-15
KR20080087128A (ko) 2008-09-30
EP2336164A1 (de) 2011-06-22
US20100261888A1 (en) 2010-10-14
CA2633554C (en) 2012-11-13
TWI369362B (en) 2012-08-01
BRPI0621124A2 (pt) 2011-11-29
EP1973942A2 (de) 2008-10-01
IL191968A0 (en) 2008-12-29
JP5036727B2 (ja) 2012-09-26
HK1119188A1 (en) 2009-07-17
AU2006343279A1 (en) 2007-11-15
WO2007130154A3 (en) 2008-06-26
TW200734351A (en) 2007-09-16
DE602007012412D1 (de) 2011-03-24
EP1973942B1 (de) 2011-02-09
US8906648B2 (en) 2014-12-09
RU2385877C1 (ru) 2010-04-10
JP2011254831A (ja) 2011-12-22
WO2007130154A8 (en) 2008-04-17
WO2007130154A2 (en) 2007-11-15

Similar Documents

Publication Publication Date Title
LTPA2019520I1 (lt) Rekombinantiniai anti-IL-23 antikūnai
NL300869I2 (nl) Olaratumab
DK2046826T3 (da) Exendin-fusionsproteiner
DK1931702T3 (da) Silkeproteiner
ZA200900229B (en) Refolding of recombinant proteins
DE602005019456D1 (de) Verdichterrad
DE602006006410D1 (de) Hermetischer verdichter
DK2314668T3 (da) Gen-inaktiverede mutanter med ændret proteinproduktion
IL191968A0 (en) Recombinant production of heparin binding proteins
GB0426160D0 (en) Production of proteins
EP1820970A4 (de) Verdichter
DE602005000066D1 (de) Verdichter
EP1826406A4 (de) Verdichter
DE602006017343D1 (de) Hermetischer verdichter
DE602005002824T8 (de) Kompressor
DE602005007683D1 (de) Verdichter
DK1809660T3 (da) Thymus-specifikt protein
DE602006010802D1 (de) Hermetischer verdichter
EP1710439A4 (de) Schwenkkompressor
EP1915531A4 (de) Verdichter
EP1961959A4 (de) Verdichter
DK1968623T3 (da) Bacteriocin-inducer-peptider
EP1937814A4 (de) Antiapoptotische proteinantikörper
DE602005002822D1 (de) Verdichter
EP1967736A4 (de) Verdichter

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1973942

Country of ref document: EP